Literature DB >> 15734937

Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.

Nathan A Johnson1, Geon-Ho Jahng, Michael W Weiner, Bruce L Miller, Helena C Chui, William J Jagust, Maria L Gorno-Tempini, Norbert Schuff.   

Abstract

PURPOSE: To prospectively determine if pulsed arterial spin-labeling perfusion magnetic resonance (MR) imaging depicts regional cerebral hypoperfusion in subjects with Alzheimer disease (AD) and mild cognitive impairment (MCI), compared with perfusion in cognitively normal (CN) subjects, that is consistent with results of fluorodeoxyglucose (FDG) positron emission tomography (PET) and hexamethylpropyleneamine oxime (HMPAO) single photon emission computed tomography (SPECT) studies of similar populations.
MATERIALS AND METHODS: Institutional review board approval and informed consent were obtained. Twenty subjects with AD (13 men, seven women; mean age, 72.9 years), 18 with MCI (nine men, nine women; mean age, 73.3 years), and 23 CN subjects (10 men, 13 women; mean age, 72.9 years) underwent arterial spin-labeling and volumetric T1-weighted structural MR imaging. Perfusion images were coregistered to structural images, corrected for partial volume effects (PVEs) with information from the structural image to determine tissue content of perfusion voxels, and normalized to a study-specific template. Analyses of perfusion differences between groups, with and without corrections for PVEs, were performed on a voxel-by-voxel basis with a one-tailed fixed-effects analysis of covariance model adjusted for age. In addition, tests were performed with and without accounting for global perfusion.
RESULTS: The AD group showed significant regional hypoperfusion, compared with the CN group, in the right inferior parietal cortex extending into the bilateral posterior cingulate gyri (P <.001), bilateral superior and middle frontal gyri (P <.001), and left inferior parietal lobe (P=.007). When PVEs from underlying cortical gray matter atrophy were accounted for, the AD group still showed hypoperfusion in the right inferior parietal lobe extending into the bilateral posterior cingulate gyri (P <.001) and left (P=.003) and right (P=.012) middle frontal gyri. With a more liberal voxel-level threshold of P <.01, the MCI group showed significant regional hypoperfusion relative to the CN group in the inferior right parietal lobe (P=.046), similar to the region of greatest significance in the AD group.
CONCLUSION: Arterial spin-labeling MR imaging showed regional hypoperfusion with AD, in brain regions similar to those seen in FDG PET and HMPAO SPECT studies of similar populations; this hypoperfusion persists after accounting for underlying cortical gray matter atrophy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15734937      PMCID: PMC1851934          DOI: 10.1148/radiol.2343040197

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  43 in total

Review 1.  Neuroimaging in dementia.

Authors:  W J Jagust
Journal:  Neurol Clin       Date:  2000-11       Impact factor: 3.806

2.  Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment.

Authors:  E Arnáiz; V Jelic; O Almkvist; L O Wahlund; B Winblad; S Valind; A Nordberg
Journal:  Neuroreport       Date:  2001-03-26       Impact factor: 1.837

3.  Detecting bilateral abnormalities with voxel-based morphometry.

Authors:  C H Salmond; J Ashburner; F Vargha-Khadem; D G Gadian; K J Friston
Journal:  Hum Brain Mapp       Date:  2000-11       Impact factor: 5.038

4.  Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease.

Authors:  K M Bradley; V T O'Sullivan; N D W Soper; Z Nagy; E M-F King; A D Smith; B J Shepstone
Journal:  Brain       Date:  2002-08       Impact factor: 13.501

5.  Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer's disease.

Authors:  Hiroshi Matsuda; Noriyuki Kitayama; Takashi Ohnishi; Takashi Asada; Seigo Nakano; Shigeki Sakamoto; Etsuko Imabayashi; Asako Katoh
Journal:  J Nucl Med       Date:  2002-03       Impact factor: 10.057

6.  Presenilin-1-associated abnormalities in regional cerebral perfusion.

Authors:  K A Johnson; F Lopera; K Jones; A Becker; R Sperling; J Hilson; J Londono; I Siegert; M Arcos; S Moreno; L Madrigal; J Ossa; N Pineda; A Ardila; M Roselli; M S Albert; K S Kosik; A Rios
Journal:  Neurology       Date:  2001-06-12       Impact factor: 9.910

7.  A voxel-based morphometric study of ageing in 465 normal adult human brains.

Authors:  C D Good; I S Johnsrude; J Ashburner; R N Henson; K J Friston; R S Frackowiak
Journal:  Neuroimage       Date:  2001-07       Impact factor: 6.556

8.  Relations between hypometabolism in the posterior association neocortex and hippocampal atrophy in Alzheimer's disease: a PET/MRI correlative study.

Authors:  K Meguro; C LeMestric; B Landeau; B Desgranges; F Eustache; J C Baron
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-09       Impact factor: 10.154

9.  Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT.

Authors:  D Kogure; H Matsuda; T Ohnishi; T Asada; M Uno; T Kunihiro; S Nakano; M Takasaki
Journal:  J Nucl Med       Date:  2000-07       Impact factor: 10.057

10.  Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia.

Authors:  A R Varma; W Adams; J J Lloyd; K J Carson; J S Snowden; H J Testa; A Jackson; D Neary
Journal:  Acta Neurol Scand       Date:  2002-04       Impact factor: 3.209

View more
  233 in total

1.  Cerebral Blood Flow Is Associated with Diagnostic Class and Cognitive Decline in Alzheimer's Disease.

Authors:  Wenna Duan; Parshant Sehrawat; Arvind Balachandrasekaran; Ashish B Bhumkar; Paresh B Boraste; James T Becker; Lewis H Kuller; Oscar L Lopez; H Michael Gach; Weiying Dai
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

2.  Comparison of relative cerebral blood flow maps using pseudo-continuous arterial spin labeling and single photon emission computed tomography.

Authors:  Peiying Liu; Jinsoo Uh; Michael D Devous; Bryon Adinoff; Hanzhang Lu
Journal:  NMR Biomed       Date:  2011-12-02       Impact factor: 4.044

3.  On the sensitivity of ASL MRI in detecting regional differences in cerebral blood flow.

Authors:  Sina Aslan; Hanzhang Lu
Journal:  Magn Reson Imaging       Date:  2010-04-27       Impact factor: 2.546

Review 4.  Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's disease.

Authors:  Cynthia M Carlsson
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

5.  Alterations in cerebral metabolic rate and blood supply across the adult lifespan.

Authors:  Hanzhang Lu; Feng Xu; Karen M Rodrigue; Kristen M Kennedy; Yamei Cheng; Blair Flicker; Andrew C Hebrank; Jinsoo Uh; Denise C Park
Journal:  Cereb Cortex       Date:  2010-11-04       Impact factor: 5.357

Review 6.  Alzheimer's silent partner: cerebral amyloid angiopathy.

Authors:  Tanya L Cupino; Matthew K Zabel
Journal:  Transl Stroke Res       Date:  2013-11-19       Impact factor: 6.829

7.  Separating function from structure in perfusion imaging of the aging brain.

Authors:  Iris Asllani; Christian Habeck; Ajna Borogovac; Truman R Brown; Adam M Brickman; Yaakov Stern
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

8.  Mineralocorticoid receptor antagonism prevents obesity-induced cerebral artery remodeling and reduces white matter injury in rats.

Authors:  Paulo W Pires; Jonathon L McClain; Sebastian F Hayoz; Anne M Dorrance
Journal:  Microcirculation       Date:  2018-06-07       Impact factor: 2.628

9.  Perfusion alterations converge with patterns of pathological spread in transactive response DNA-binding protein 43 proteinopathies.

Authors:  Pilar M Ferraro; Charles Jester; Christopher A Olm; Katerina Placek; Federica Agosta; Lauren Elman; Leo McCluskey; David J Irwin; John A Detre; Massimo Filippi; Murray Grossman; Corey T McMillan
Journal:  Neurobiol Aging       Date:  2018-04-17       Impact factor: 4.673

10.  Genetic heterogeneity of Alzheimer's disease in subjects with and without hypertension.

Authors:  Alireza Nazarian; Konstantin G Arbeev; Arseniy P Yashkin; Alexander M Kulminski
Journal:  Geroscience       Date:  2019-05-05       Impact factor: 7.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.